Response to “Cancer care in the pediatric surgical patient: A paradigm to abolish volume-outcome disparities in surgery”

Surgery. 2010 Feb;147(2):310-311, Elvira C. van Dalen, Renée L. Mulder, Huib N. Caron, Leontien C.M. Kremer

To the Editors:We read with interest the article by Gutierrez et al,1 who addressed the important question of whether children diagnosed with neuroblastoma or Wilms tumor treated at a high-volume center had a better survival than children treated at a low-volume center. Gutierrez et al1 defined high-volume centers as centers that cumulatively treated more than approximately 50% of patients for each diagnosis; the remainder were classified as low-volume centers. For both tumors, no statistically significant...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Editors' Choice

Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration